Mergers & Acquisitions

Mergers and acquisitions have long accounted for roughly 90% of all exits from venture-backed businesses for founders and investors, and we begin positioning our clients at their earliest stages to be ready for acquisition when the conditions are right. We are by your side, each step of the way, guiding you through all of the relevant issues:

• Corporate structure and strategy
• Capital raising
• Employment and executive compensation
• Licensing, strategic partnering and commercial transactions
• Tax planning and compliance

One of our most common transaction types is the sale of a client company to a mature tech or life sciences “serial” acquirer. That’s why you won’t see those “mega-cap” tech and life sciences companies on our list of clients. Working for them would limit our ability to represent our primary clients: the most innovative and nimble companies coming to market today.

Because we focus on serving private founder-led and/or venture-backed companies, we understand the changing needs and objectives of companies as they mature toward an exit. We tailor our advice to their unique assets and situation, even as we help them avoid potential landmines and position them for a successful acquisition.

Major corporate acquirers active in the tech and life sciences space know us well because we have been in front of them repeatedly. We understand their business drivers, interests, and legal teams, which enables us to find solutions to even the thorniest issues. These companies and their lawyers know that we’ll be formidable in representing the interests of our sell-side clients, but they also know that we’ll work diligently to get the deal done.

The types of sell-side M&A transactions we handle are as diverse as the companies we represent, the companies acquiring them, the financial and market conditions the parties encounter, and the business demands of the industries in which all of the parties operate.

Having completed thousands of transactions, our M&A team has experience not only counseling founder-led companies through their acquisition by a more mature strategic acquirer, but also handling transactions such as:

• Sales of public companies, including strategic sales and take-privates
• Private Equity acquisitions and leveraged buyouts
• Mergers of equals (MoEs)
• Auction processes
• Dual track M&A/IPO processes
• Business-line divestitures
• SPACs and DeSPACs
• Board Special Committee representations
• Special counsel to investment funds for M&A sales of their portfolio companies

Regardless of the structure of the transaction or engagement, we offer strategic counsel and meticulous execution focused on optimizing outcomes.

Our practical guidance and insight into business opportunities become even more valuable as our clients mature and grow. We advise both public and private companies on growth initiatives, including acquisitions and business combinations.

In buy-side M&A, our attorneys bring their deep knowledge of the life sciences and technology industries to negotiate favorable acquisition terms, protecting our clients’ interests while facilitating successful transactions. We serve as strategic partners throughout the acquisition process, conducting thorough due diligence and navigating complex legal landscapes to get deals done.

With a focus on efficiency and results, we streamline the acquisition process, from initial target identification to post-closing integration. We drive your buy-side M&A objectives forward, minimizing risk and maximizing value every step of the way.